Wednesday, April 10, 2019

Cullgen Collects $16M

San Diego-based biotechnology company Cullgen has raised $16M in a Series A funding, to go towards possible treatments for cancer, inflammatory, and autoimmune diseases, the company said this morning. The funding came from Sequoia Capital China and Highlight Capital. According to Cullgen, the funding round will go towards its development of its internal

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.